Advanced Tissue Sciences Announces Effectiveness of S-3 Registration.Business Editors & Health/Medical Writers BIOWIRE2K LA JOLLA La Jolla (lə hoi`yə), on the Pacific Ocean, S Calif., an uninc. district within the confines of San Diego; founded 1869. The beautiful ocean beaches, in particular La Jolla shores and Black's Beach, and sea-washed caves attract visitors and , Calif.--(BW HealthWire)--Feb. 11, 2002 Advanced Tissue Sciences, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : ATIS ATIS - A Tools Integration Standard ) today announced the effectiveness of an S-3 Registration Statement covering 14,014,842 shares of its common stock. These include 5,376,344 shares purchased by Medtronic Asset Management, Inc., as announced on Oct. 3, 2001; 3,534,335 shares sold in a private placement led by the State of Wisconsin Investment Board and announced on Nov. 5, 2001; and 5,104,163 shares acquired by Smith & Nephew SNATS SNATS Systems Network Architecture Transaction Service (IBM) , Inc., as announced on Jan. 5, 1999. Advanced Tissue Sciences is a tissue engineering company utilizing its proprietary core technology to develop and manufacture human-based tissue products for tissue repair and transplantation. For additional information or a copy of the prospectus contact: Abe Wischnia, Senior Director of Investor Relations Investor relations The process by which the corporation communicates with its investors. , Advanced Tissue Sciences, Inc., 10933 Torrey Pines Road, La Jolla, California 92037. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion